NitroMed's IPO

NitroMed raised a round of funding on November 06, 2003. Investors include Public.

NitroMed, Inc. of Lexington, Massachusetts is a pharmaceutical company and the maker of BiDil, an orally administered medicine available in the United States for the treatment of heart failure in self…

Articles about NitroMed's IPO: